Securities code: 002317 Announcement No.: 2022-013
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317)
Notice of the board of supervisors on the company’s restricted stock incentive plan in 2022
Verification opinions and publicity of the list of incentive objects
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) (hereinafter referred to as “the company”) held the 16th meeting of the 7th board of directors and the 9th meeting of the 7th board of supervisors on February 11, 2022, deliberated and adopted the proposal on and its summary and other proposals.
In accordance with the measures for the administration of equity incentive of listed companies (hereinafter referred to as the “measures”), the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – business handling (hereinafter referred to as the “self regulatory guidelines”), the articles of association and other relevant laws, regulations and normative documents, The list of incentive objects of the company’s restricted stock incentive plan in 2022 was publicized within the company. The board of supervisors of the company reviewed the list of incentive objects of the company’s restricted stock incentive plan in 2022 in combination with the publicity. The relevant publicity and verification methods are as follows:
1、 Publicity and verification of the list of incentive objects
(I) publicity
On February 12, 2022, the company disclosed the Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) 2022 restricted stock incentive plan (Draft), the list of incentive objects of Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) 2022 restricted stock incentive plan and other announcements, From February 14, 2022, the names and positions of the incentive objects of the 2022 restricted stock incentive plan (hereinafter referred to as the “incentive plan”) have been publicized within the company.
1. Publicity content: the name and position of the incentive object of the company’s restricted stock incentive plan in 2022;
2. Publicity time: February 14, 2022 to February 23, 2022;
Securities code: 002317 Announcement No.: 2022-013
3. Publicity method: publicize the list of incentive objects through the company’s internal office system;
4. Feedback method: during the publicity period, the company’s employees can give feedback to the company’s board of supervisors by telephone, e-mail or in writing;
5. Publicity result: no organization or individual raised any objection within the publicity time limit.
(II) verification
The board of supervisors of the company has verified the list of incentive objects, ID cards, labor contracts signed between incentive objects and the company (including holding subsidiaries), positions held in the company (including holding subsidiaries) and their employment, etc.
2、 Verification opinions of the board of supervisors
In accordance with the provisions of relevant laws, regulations and normative documents such as the management measures, the guide to self regulatory supervision and the articles of association, the board of supervisors checked the list of incentive objects of the incentive plan and issued the following verification opinions:
(I) the personnel listed in the list of incentive objects granted by the incentive plan have the qualifications specified in the company law, the articles of association and other laws, regulations and normative documents.
(II) there is no circumstance that the incentive object shall not be an incentive object as stipulated in Article 8 of the administrative measures: 1. It has been identified as an inappropriate candidate by the stock exchange in the last 12 months;
2. In the last 12 months, it has been identified as an inappropriate candidate by the CSRC and its dispatched offices;
3. Being administratively punished by the CSRC and its dispatched offices or taking market entry prohibition measures for major violations of laws and regulations in the last 12 months;
4. Those who are not allowed to serve as directors or senior managers of the company as stipulated in the company law;
5. Those who are not allowed to participate in the equity incentive of listed companies according to laws and regulations;
6. Other circumstances recognized by the CSRC.
(III) the personnel listed in the list of incentive objects of the incentive plan meet the incentive object conditions specified in the management measures and other documents, and meet the incentive object conditions specified in the incentive plan.
(IV) the incentive objects of this incentive plan do not include the company’s supervisors, independent directors, shareholders or actual controllers who individually or jointly hold more than 5% of the company’s shares and their spouses, parents and children.
In conclusion, the board of supervisors of the company believes that the incentive objects listed in the incentive plan meet the incentive object conditions specified in relevant laws, regulations, normative documents and the incentive plan, and their subject qualification as the incentive object of the company’s incentive plan is legal and effective.
Securities code: 002317 Announcement No.: 2022-013
It is hereby announced.
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) board of supervisors February 24, 2002
